CalAmp Corp. (CAMPQ)
OTCMKTS · Delayed Price · Currency is USD
0.0700
+0.0300 (75.00%)
Inactive · Last trade price on Jul 31, 2024
CalAmp Employees
CalAmp had 644 employees as of February 28, 2023. The number of employees decreased by 243 or -27.40% compared to the previous year.
Employees
644
Change (1Y)
-243
Growth (1Y)
-27.40%
Revenue / Employee
$411,081
Profits / Employee
-$157,377
Market Cap
120.57K
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Feb 28, 2023 | 644 | -243 | -27.40% |
| Feb 28, 2022 | 887 | -96 | -9.77% |
| Feb 28, 2021 | 983 | -97 | -8.98% |
| Feb 29, 2020 | 1,080 | 198 | 22.45% |
| Feb 28, 2019 | 882 | 42 | 5.00% |
| Feb 28, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 29, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
CalAmp News
- 14 days ago - Hyped Token Launches Fall Flat as TGE Loses Mojo Ahead of Airdrop Season - CoinDesk
- 23 days ago - CAMP4 Therapeutics Initiates GLP Toxicology Studies for CMP-SYNGAP-01 - GlobeNewsWire
- 4 weeks ago - CAMP4 Therapeutics Corporation (CAMP) Upgraded to Buy: Here's What You Should Know - Nasdaq
- 5 weeks ago - Camp4 Therapeutics (CAMP) Downgraded by JP Morgan to Neutral | CAMP Stock News - GuruFocus
- 6 weeks ago - Camp4 Therapeutics (CAMP) Secures $100 Million in Private Placement - GuruFocus
- 6 weeks ago - CAMP4 Announces an Oversubscribed Private Placement of up to $100 Million to Advance First-in-Class Treatment for SYNGAP1-Related Disorders - GlobeNewsWire
- 2 months ago - CAMP4 Reports Second Quarter 2025 Financial Results and Corporate Highlights - GlobeNewsWire
- 5 months ago - CAMP4 Presents Translational Data from SYNGAP1-Related Disorders Program Showcasing Increased Protein in Non-Human Primates and Reviews Preclinical and Detailed Single Ascending Dose Safety Data from Urea Cycle Disorders Program at the 28th American Society of Gene and Cell Therapy Annual Meeting - GlobeNewsWire